Newron Pharmaceuticals SpA ( ($CH:NWRN) ) has shared an announcement. Newron Pharmaceuticals announced the presentation of data on Evenamide, its ...

Equillium, Inc. raises $50M to advance EQ504, a novel AhR modulator for ulcerative colitis. Phase 1 trials begin mid-2026. Click for more on EQ stock prospects.

Cavion presents data that its calcium channel modulator CX-8998 significantly suppresses seizures in GAERS and WAG/Rij rat models of absence epilepsy ...

Infectious diseases can have very different effects on different people; some individuals may have virtually no symptoms from COVID-19, for example, while others are killed by the viral disease.

Neoadjuvant androgen deprivation therapy with enzalutamide plus the glucocorticoid receptor modulator relacorilant versus placebo for patients with high-risk localized prostate cancer.